Our Company
BIOMATCAN Ltd. is a private medical device company specializing in the research, development, manufacturing and the marketing of innovative biomaterial products for orthopedic and dental applications worldwide. BIOMATCAN’s technology is dedicated to bone-like substitute bioceramics which fall under synthetic bone substitutes or orthobiologics product categories.
The Need
There is a need for a safe biocompatible synthetic material that can be used to replace or augment bone.
The Global Bone Grafts and substitutes Market is expected to reach 6.9 billion by 2026 at CAGR of 5.7%. Bone grafts are used as a filler and scaffold to facilitate bone formation and promote wound healing. These grafts are bioresorbable and have no antigen-antibody reaction. It act as a mineral reservoir which induces new bone formation. Bone grafting is basically a surgical procedure that replaces missing bone with material from patient′s own body, an artificial, synthetic, or natural substitute. Bone grafting is possible because of the ability of bone tissue to regenerate completely if provided the space into which it has to grow. As natural bone grows, it generally replaces the graft material completely, resulting in a fully integrated region of new bone.
The Global Bone Grafts and substitutes Market is expected to reach 6.9 billion by 2026 at CAGR of 5.7%. Bone grafts are used as a filler and scaffold to facilitate bone formation and promote wound healing. These grafts are bioresorbable and have no antigen-antibody reaction. It act as a mineral reservoir which induces new bone formation. Bone grafting is basically a surgical procedure that replaces missing bone with material from patient′s own body, an artificial, synthetic, or natural substitute. Bone grafting is possible because of the ability of bone tissue to regenerate completely if provided the space into which it has to grow. As natural bone grows, it generally replaces the graft material completely, resulting in a fully integrated region of new bone.
Our Solution
BIOMATCAN'S line of products offer a safe and cost effective bioactive solution to bone generation. Our bone graft substitutes are produced through BIOMATCAN's innovative production process and are manufactured, packaged and gamma sterilized under strict quality conditions.
Our products are fully synthetic: they contain no human or animal tissue, so there is no risk of disease transmission or rejection. They can be made in consistent, high quality batches, with no limits on supply.
Our products are fully synthetic: they contain no human or animal tissue, so there is no risk of disease transmission or rejection. They can be made in consistent, high quality batches, with no limits on supply.
